Unichem Laboratories Limited (BOM:506690)

Market Cap	37.93B +6.9%
Revenue (ttm)	23.17B +7.5%
Net Income	3.05B +143.9%
EPS	43.19 +143.1%
Shares Out	70.41M
PE Ratio	12.47
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,428
Open	549.60
Previous Close	538.80
Day's Range	530.00 - 552.35
52-Week Range	280.00 - 685.95
Beta	-0.01
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About Unichem Laboratories

Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products in Asia, Europe, Africa, CIS, the United States, and internationally. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, formulations, bu...

• Industry: Pharmaceutical Preparations
• Founded: 1944
• Employees: 2,780
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 506690

Financial Performance

In fiscal year 2026, Unichem Laboratories's revenue was 22.02 billion, an increase of 4.31% compared to the previous year's 21.11 billion. Earnings were 2.53 billion, an increase of 83.86%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 17, 2026

Data Sources Report a data error